Cytosorbents Crp Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Cytosorbents Crp Stock Summary

Cytosorbents Crp competes with LivaNova PLC, Electromed, Orthopediatrics Corp, SurModics, and Neuropace. Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey. Cytosorbents Cor operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 221 people.

Cytosorbents Crp Key Financial Ratios

Cytosorbents Crp Key Balance Sheet Accounts

Cytosorbents Crp Key Income Statement Accounts

Cytosorbents Crp Key Cash Accounts

Cytosorbents Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cytosorbents Crp's current stock value. Our valuation model uses many indicators to compare Cytosorbents Crp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cytosorbents Crp competition to find correlations between indicators driving Cytosorbents Crp's intrinsic value. More Info.Cytosorbents Crp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Cytosorbents Crp's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cytosorbents Crp's earnings, one of the primary drivers of an investment's value.

Cytosorbents Crp Systematic Risk

Today, most investors in Cytosorbents Crp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cytosorbents Crp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cytosorbents Crp growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Cytosorbents Crp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cytosorbents Crp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cytosorbents Crp based on widely used predictive technical indicators. In general, we focus on analyzing Cytosorbents Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cytosorbents Crp's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.